Santen Pharmaceutical Co., Ltd. ( SNPHY) - Stock Earnings
SNPHY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 40.9 million USD | 478.0 million USD |
| 2025Q3 | 55.4 million USD | 475.3 million USD |
| 2025Q4 | 51.2 million USD | 473.6 million USD |
| 2026Q2 Est. | — | — |
SNPHY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -112.5 million USD | 2.1 billion USD |
| 2024 | 176.0 million USD | 2.0 billion USD |
| 2025 | 242.7 million USD | 2.0 billion USD |
| 2026 Est. | — | — |
SNPHY
Price: $11.88
52 week price:
Dividend Yield: 1.87%
Dividend Per Share: 0.22 USD
Earnings Per Share: 0.72 USD
P/E Ratio: 16.53
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 3.8 billion